Cue Biopharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLEICHROEDER LP | 11/13/2024 | 5.00 M | $3.78 M | 74.63% | 9.75% |
| SLATE PATH CAPITAL LP | 11/14/2024 | 2.40 M | $1.82 M | 0.00% | 4.69% |
| VANGUARD GROUP INC | 11/13/2024 | 2.03 M | $1.54 M | 0.00% | 3.97% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 570,975 | $432,342 | 100.00% | 1.11% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 508,827 | $385,370 | 3.32% | 0.99% |
| ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC | 11/12/2024 | 478,500 | $362,320 | 0.00% | 0.93% |
| SIGMA PLANNING CORP | 11/04/2024 | 401,325 | $303,883 | 50.86% | 0.78% |
| GOOD LIFE ADVISORS, LLC | 10/16/2024 | 400,000 | $302,880 | 23.08% | 0.78% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 358,974 | $271,815 | -27.33% | 0.70% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 291,663 | $221,000 | 5.08% | 0.57% |
| ADVISORY RESEARCH INC | 11/14/2024 | 257,225 | $194,771 | 0.00% | 0.50% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 239,202 | $181,077 | -1.39% | 0.47% |
| STIFEL FINANCIAL CORP | 11/14/2024 | 194,222 | $147,067 | 0.12% | 0.38% |
| STATE STREET CORP | 11/14/2024 | 177,053 | $134,065 | 0.00% | 0.35% |
| HIGHTOWER ADVISORS, LLC | 11/14/2024 | 83,284 | $64,000 | 0.00% | 0.16% |
| UBS GROUP AG | 11/14/2024 | 74,175 | $56,150 | 25.69% | 0.14% |
| MORGAN STANLEY | 11/14/2024 | 33,692 | $25,512 | -72.16% | 0.07% |
| XTX TOPCO LTD | 11/14/2024 | 27,665 | $20,948 | 100.00% | 0.05% |
| JANE STREET GROUP, LLC | 11/15/2024 | 25,935 | $19,638 | -73.70% | 0.05% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 24,672 | $18,682 | -69.25% | 0.05% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 11/14/2024 | 24,098 | $18,247 | -54.56% | 0.05% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 20,077 | $15,202 | -2.93% | 0.04% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 10/28/2024 | 20,000 | $15,000 | -9.91% | 0.04% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 18,563 | $14,056 | -93.03% | 0.04% |
| LPL FINANCIAL LLC | 11/08/2024 | 17,925 | $13,573 | 0.00% | 0.04% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 14,575 | $10,896 | -93.19% | 0.03% |
| CITADEL ADVISORS LLC | 11/14/2024 | 14,400 | $10,904 | 12.50% | 0.03% |
| SEACREST WEALTH MANAGEMENT, LLC | 10/16/2024 | 13,000 | $9,844 | 0.00% | 0.03% |
| BEACON POINTE ADVISORS, LLC | 11/14/2024 | 10,000 | $7,572 | 0.00% | 0.02% |
| LEGACY CAPITAL GROUP CALIFORNIA, INC. | 10/23/2024 | 10,000 | $7,572 | 0.00% | 0.02% |
| 11/14/2024 | 9,000 | $6,814 | 0.00% | 0.02% | |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 7,217 | $5,463 | -36.59% | 0.01% |
| BARCLAYS PLC | 11/19/2024 | 6,029 | $5,000 | -67.05% | 0.01% |
| GLEASON GROUP, INC. | 10/15/2024 | 6,000 | $4,543 | 0.00% | 0.01% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 4,056 | $3,000 | 100.00% | 0.01% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 11/12/2024 | 3,000 | $2,272 | 0.00% | 0.01% |
| CITADEL ADVISORS LLC | 11/14/2024 | 2,600 | $1,969 | -76.58% | 0.01% |
| NEWEDGE ADVISORS, LLC | 11/14/2024 | 2,550 | $1,931 | 0.00% | 0.01% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/12/2024 | 2,500 | $1,893 | 400.00% | 0.00% |
| LARSON FINANCIAL GROUP LLC | 11/12/2024 | 1,400 | $1,060 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/08/2024 | 904 | $685 | 0.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 11/04/2024 | 439 | $332 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 380 | $288 | 0.00% | 0.00% |
| FMR LLC | 11/13/2024 | 285 | $216 | -96.17% | 0.00% |
| SUNBELT SECURITIES, INC. | 11/18/2024 | 237 | $179 | 0.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 11/06/2024 | 215 | $163 | 0.00% | 0.00% |
| ARMSTRONG ADVISORY GROUP, INC | 10/11/2024 | 120 | $91 | 0.00% | 0.00% |
| POINT72 (DIFC) LTD | 11/14/2024 | 58 | $44 | -99.50% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| COMERICA BANK | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Cue Biopharma, Inc.institutional Ownership - FAQ's
During the previous two years, 84 institutional investors and hedge funds held shares of Cue Biopharma, Inc.. The most heavily invested institutionals were:
Bleichroeder LP: 5 M
Slate Path Capital LP: 2.4 M
VANGUARD GROUP INC: 2.03 M
BlackRock Funding, Inc. /DE: 570,975
GEODE CAPITAL MANAGEMENT, LLC: 508,827
Robertson Stephens Wealth Management, LLC: 478,500
27.15% of Cue Biopharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 14.69 M shares in the last 24 months. This purchase volume represents approximately $14.83 M in transactions.